Sun, 02-Apr-2023


ViiV Healthcare Announces US FDA Approval for Rukobi...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the US Food and Drug Administration (FDA) has approved Rukobia (f... July 3, 2020 12:39 pm By Neha Mule

Gilead Prices COVID-19 Drug Candidate Remdesivir at ...

Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day cou... June 29, 2020 12:33 pm By Neha Mule

Rybelsus Approved in Japan for the Treatment of Type...

Novo Nordisk today announced that the Japanese Ministry of Health, Labour and Welfare has approved Rybelsus (oral semaglutide), the first and only oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) in a... June 29, 2020 8:32 am By Neha Mule

Carlyle Buys 20% Stake in Piramal Pharma Businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday. ... June 27, 2020 10:31 am By Neha Mule

Sanofi Planning to Cut up to 1,680 Jobs in Europe

Sanofi said on Friday it is planning to slash up to 1,680 jobs in Europe, confirming what two sources familiar with the matter had previously told Reuters. One source said the cuts would be carried out ... June 26, 2020 11:15 am By Neha Mule

Zogenix Announces FDA Approval for FINTEPLA for the ...

Zogenix, Inc., a pharmaceutical company developing rare disease therapies, announced that the U.S. Food and Drug Administration (FDA) has approved FINTEPLA (fenfluramine) oral solution, CIV for the treatment ... June 26, 2020 10:07 am By Neha Mule

Cipla to Price Remdesivir Version for COVID-19 Under...

Indian drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc’s antiviral drug remdesivir for use in COVID-19 patients at less than 5,000 rupees ($66), the company said. Cipla and p... June 23, 2020 2:14 pm By Neha Mule

Related News